Abstract
ObjectivesThe economic implications of combining rezvilutamide with androgen deprivation therapy (ADT) remain uncertain, despite the observed survival advantages compared with bicalutamide plus ADT. Therefore, this study evaluates the cost-effectiveness of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have